Press Releases 2013

May 17, 2013
Galapagos creates new warrant plan
View English version - Bekijk Nederlandse versie

May 17, 2013
AbbVie and Galapagos extend GLPG0634 collaboration to include Crohn's disease
View English version - Bekijk Nederlandse versie

May 17, 2013
Galapagos business update
View English version - Bekijk Nederlandse versie

 May 13, 2013
Galapagos to present three posters on GLPG0634 at EULAR
View English version - Bekijk Nederlandse versie

April 30, 2013
NYSE Liffe lists Equity Options on Galapagos
View English version - Bekijk Nederlandse versie

April 29, 2013
Galapagos completes private placement by issuance of 2,696,831 new ordinary shares
View English version - Bekijk Nederlandse versie

April 24, 2013
Galapagos raises €54 million
View English version - Bekijk Nederlandse versie

 April 24, 2013
Galapagos to raise capital via a private placement of new shares
View English version - Bekijk Nederlandse versie

April 23, 2013
Galapagos starts Phase 2A study with GLPG0974 in ulcerative colitis
View English version - Bekijk Nederlandse versie

April 22, 2013
Galapagos discovers novel candidate drug to treat breast cancer
View English version - Bekijk Nederlandse versie

 April 16, 2013
Galapagos presents scope of GLPG0634 Phase 2b program
View English version - Bekijk Nederlandse versie

April 12, 2013
Gestion notify of 4.97% shareholding in Galapagos
View English version - Bekijk Nederlandse versie

 April 8, 2013
Galapagos increases share capital through warrant exercises
View English version - Bekijk Nederlandse versie

March 27, 2013
Galapagos to start Phase 2a study with GLPG0974 in IBD patients
View English version - Bekijk Nederlandse versie

March 27, 2013
Galapagos gives R&D Update
View webcast presentation
View English version - Bekijk Nederlandse versie

March 20, 2013
Galapagos to host annual R&D Update on 27 March
View English version - Bekijk Nederlandse versie

March 8, 2013
Galapagos reports record revenues in 2012, increasing momentum in clinical pipeline
View webcast presentation
View English version - Bekijk Nederlandse versie
View Financial Tables - Bekijk Financiële Tabellen

March 8, 2013
Galapagos and Roche conclude strategic alliance
View English version - Bekijk Nederlandse versie

March 6, 2013
Galapagos receives €7.5 million in Servier alliances 
View English version - Bekijk Nederlandse versie

 March 4, 2013
Katrine Bosley appointed to Galapagos' Board of Directors
View English version - Bekijk Nederlandse versie

 February 5, 2013
Galapagos announces GSK2586184 JAK1 molecule progresses to Phase 2 studies
View English version - Bekijk Nederlandse versie

January 30, 2013
Galapagos receives €2.5 million IWT grant for IBD research
View English version - Bekijk Nederlandse versie

 January 16, 2013
Galapagos delivers candidate drug in its alliance with Janssen Pharmaceutica NV and receives €4 million milestone payment
View English version - Bekijk Nederlandse versie

 January 15, 2013
Galapagos acquires Cangenix, a structure-based drug discovery company
View English version - Bekijk Nederlandse versie

 January 15, 2013
Galapagos creates Fidelta, a third Galapagos service division
View English version - Bekijk Nederlandse versie

 January 10, 2013
Galapagos receives €2.7 million IWT grant for antibacterial research
View English version - Bekijk Nederlandse versie

 January 9, 2013
Galapagos delivers candidate drug in GSK alliance and receives milestone payment
View English version - Bekijk Nederlandse versie

 January 6, 2013
Galapagos to present at the 31st annual J. P. Morgan Healthcare Conference
View webcast presentation
View English version - Bekijk Nederlandse versie